nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGA2B—hematopoietic system—hematologic cancer	0.0228	0.139	CbGeAlD
Tirofiban—ITGB3—hematopoietic system—hematologic cancer	0.0199	0.122	CbGeAlD
Tirofiban—ITGA2B—blood—hematologic cancer	0.0151	0.0923	CbGeAlD
Tirofiban—ITGA2B—bone marrow—hematologic cancer	0.0146	0.0893	CbGeAlD
Tirofiban—ITGA2B—lung—hematologic cancer	0.0132	0.0809	CbGeAlD
Tirofiban—ITGB3—blood—hematologic cancer	0.0132	0.0807	CbGeAlD
Tirofiban—ITGB3—bone marrow—hematologic cancer	0.0128	0.0781	CbGeAlD
Tirofiban—ITGA2B—testis—hematologic cancer	0.0125	0.0764	CbGeAlD
Tirofiban—ITGB3—lung—hematologic cancer	0.0116	0.0707	CbGeAlD
Tirofiban—ITGB3—testis—hematologic cancer	0.0109	0.0667	CbGeAlD
Tirofiban—ITGA2B—lymph node—hematologic cancer	0.00904	0.0553	CbGeAlD
Tirofiban—ITGB3—lymph node—hematologic cancer	0.0079	0.0484	CbGeAlD
Tirofiban—Hypertension—Gemcitabine—hematologic cancer	0.00027	0.00075	CcSEcCtD
Tirofiban—Hyperhidrosis—Alitretinoin—hematologic cancer	0.00027	0.00075	CcSEcCtD
Tirofiban—Dizziness—Nilotinib—hematologic cancer	0.00027	0.000749	CcSEcCtD
Tirofiban—Anaphylactic shock—Vincristine—hematologic cancer	0.000269	0.000747	CcSEcCtD
Tirofiban—Oedema—Vincristine—hematologic cancer	0.000269	0.000747	CcSEcCtD
Tirofiban—Dizziness—Imatinib—hematologic cancer	0.000268	0.000745	CcSEcCtD
Tirofiban—Hypersensitivity—Melphalan—hematologic cancer	0.000268	0.000744	CcSEcCtD
Tirofiban—Nausea—Procarbazine—hematologic cancer	0.000268	0.000743	CcSEcCtD
Tirofiban—Hyperhidrosis—Ifosfamide—hematologic cancer	0.000267	0.000741	CcSEcCtD
Tirofiban—Dizziness—Cladribine—hematologic cancer	0.000264	0.000732	CcSEcCtD
Tirofiban—Thrombocytopenia—Vincristine—hematologic cancer	0.000263	0.000732	CcSEcCtD
Tirofiban—Nausea—Bexarotene—hematologic cancer	0.000262	0.000729	CcSEcCtD
Tirofiban—Nausea—Dasatinib—hematologic cancer	0.000262	0.000729	CcSEcCtD
Tirofiban—Oedema—Irinotecan—hematologic cancer	0.000262	0.000728	CcSEcCtD
Tirofiban—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.000262	0.000728	CcSEcCtD
Tirofiban—Oedema—Mitoxantrone—hematologic cancer	0.000262	0.000728	CcSEcCtD
Tirofiban—Anaphylactic shock—Irinotecan—hematologic cancer	0.000262	0.000728	CcSEcCtD
Tirofiban—Nausea—Fludarabine—hematologic cancer	0.000262	0.000726	CcSEcCtD
Tirofiban—Hypersensitivity—Lenalidomide—hematologic cancer	0.000261	0.000724	CcSEcCtD
Tirofiban—Hyperhidrosis—Vincristine—hematologic cancer	0.00026	0.000722	CcSEcCtD
Tirofiban—Pain—Thiotepa—hematologic cancer	0.000259	0.000721	CcSEcCtD
Tirofiban—Urticaria—Bortezomib—hematologic cancer	0.000259	0.000718	CcSEcCtD
Tirofiban—Body temperature increased—Bortezomib—hematologic cancer	0.000257	0.000714	CcSEcCtD
Tirofiban—Bradycardia—Betamethasone—hematologic cancer	0.000257	0.000714	CcSEcCtD
Tirofiban—Bradycardia—Dexamethasone—hematologic cancer	0.000257	0.000714	CcSEcCtD
Tirofiban—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000257	0.000713	CcSEcCtD
Tirofiban—Thrombocytopenia—Mitoxantrone—hematologic cancer	0.000257	0.000713	CcSEcCtD
Tirofiban—Thrombocytopenia—Irinotecan—hematologic cancer	0.000257	0.000713	CcSEcCtD
Tirofiban—Urticaria—Bleomycin—hematologic cancer	0.000257	0.000712	CcSEcCtD
Tirofiban—Headache—Nilotinib—hematologic cancer	0.000256	0.00071	CcSEcCtD
Tirofiban—Body temperature increased—Bleomycin—hematologic cancer	0.000255	0.000709	CcSEcCtD
Tirofiban—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000255	0.000709	CcSEcCtD
Tirofiban—Oedema—Gemcitabine—hematologic cancer	0.000255	0.000709	CcSEcCtD
Tirofiban—Headache—Imatinib—hematologic cancer	0.000254	0.000706	CcSEcCtD
Tirofiban—Haemoglobin—Dexamethasone—hematologic cancer	0.000254	0.000705	CcSEcCtD
Tirofiban—Haemoglobin—Betamethasone—hematologic cancer	0.000254	0.000705	CcSEcCtD
Tirofiban—Hyperhidrosis—Irinotecan—hematologic cancer	0.000253	0.000704	CcSEcCtD
Tirofiban—Hyperhidrosis—Mitoxantrone—hematologic cancer	0.000253	0.000704	CcSEcCtD
Tirofiban—Dizziness—Vinblastine—hematologic cancer	0.000253	0.000702	CcSEcCtD
Tirofiban—Haemorrhage—Betamethasone—hematologic cancer	0.000252	0.000701	CcSEcCtD
Tirofiban—Haemorrhage—Dexamethasone—hematologic cancer	0.000252	0.000701	CcSEcCtD
Tirofiban—Urticaria—Vinorelbine—hematologic cancer	0.000252	0.000701	CcSEcCtD
Tirofiban—Body temperature increased—Vinorelbine—hematologic cancer	0.000251	0.000698	CcSEcCtD
Tirofiban—Pain—Thalidomide—hematologic cancer	0.000251	0.000697	CcSEcCtD
Tirofiban—Thrombocytopenia—Gemcitabine—hematologic cancer	0.00025	0.000694	CcSEcCtD
Tirofiban—Headache—Cladribine—hematologic cancer	0.00025	0.000694	CcSEcCtD
Tirofiban—Nausea—Chlorambucil—hematologic cancer	0.000248	0.000688	CcSEcCtD
Tirofiban—Hyperhidrosis—Gemcitabine—hematologic cancer	0.000247	0.000685	CcSEcCtD
Tirofiban—Nausea—Nilotinib—hematologic cancer	0.000242	0.000673	CcSEcCtD
Tirofiban—Urticaria—Thiotepa—hematologic cancer	0.000241	0.000669	CcSEcCtD
Tirofiban—Pain—Carmustine—hematologic cancer	0.000241	0.000669	CcSEcCtD
Tirofiban—Nausea—Imatinib—hematologic cancer	0.000241	0.000669	CcSEcCtD
Tirofiban—Myocardial infarction—Prednisone—hematologic cancer	0.00024	0.000667	CcSEcCtD
Tirofiban—Body temperature increased—Thiotepa—hematologic cancer	0.00024	0.000666	CcSEcCtD
Tirofiban—Hypersensitivity—Bortezomib—hematologic cancer	0.00024	0.000666	CcSEcCtD
Tirofiban—Headache—Vinblastine—hematologic cancer	0.00024	0.000665	CcSEcCtD
Tirofiban—Pain—Alitretinoin—hematologic cancer	0.000239	0.000663	CcSEcCtD
Tirofiban—Anaphylactic shock—Cisplatin—hematologic cancer	0.000238	0.000661	CcSEcCtD
Tirofiban—Oedema—Cisplatin—hematologic cancer	0.000238	0.000661	CcSEcCtD
Tirofiban—Hypersensitivity—Bleomycin—hematologic cancer	0.000238	0.000661	CcSEcCtD
Tirofiban—Nausea—Cladribine—hematologic cancer	0.000237	0.000658	CcSEcCtD
Tirofiban—Pain—Ifosfamide—hematologic cancer	0.000236	0.000655	CcSEcCtD
Tirofiban—Hypersensitivity—Vinorelbine—hematologic cancer	0.000234	0.00065	CcSEcCtD
Tirofiban—Dizziness—Lenalidomide—hematologic cancer	0.000234	0.000649	CcSEcCtD
Tirofiban—Urticaria—Thalidomide—hematologic cancer	0.000233	0.000647	CcSEcCtD
Tirofiban—Thrombocytopenia—Cisplatin—hematologic cancer	0.000233	0.000647	CcSEcCtD
Tirofiban—Body temperature increased—Thalidomide—hematologic cancer	0.000232	0.000644	CcSEcCtD
Tirofiban—Hypertension—Etoposide—hematologic cancer	0.000231	0.00064	CcSEcCtD
Tirofiban—Dizziness—Hydroxyurea—hematologic cancer	0.000231	0.00064	CcSEcCtD
Tirofiban—Pain—Vincristine—hematologic cancer	0.00023	0.000639	CcSEcCtD
Tirofiban—Hyperhidrosis—Cisplatin—hematologic cancer	0.00023	0.000639	CcSEcCtD
Tirofiban—Hypertension—Prednisolone—hematologic cancer	0.000227	0.000632	CcSEcCtD
Tirofiban—Nausea—Vinblastine—hematologic cancer	0.000227	0.000631	CcSEcCtD
Tirofiban—Pain—Irinotecan—hematologic cancer	0.000224	0.000622	CcSEcCtD
Tirofiban—Pain—Mitoxantrone—hematologic cancer	0.000224	0.000622	CcSEcCtD
Tirofiban—Bradycardia—Prednisone—hematologic cancer	0.000224	0.000622	CcSEcCtD
Tirofiban—Hypersensitivity—Thiotepa—hematologic cancer	0.000224	0.000621	CcSEcCtD
Tirofiban—Body temperature increased—Carmustine—hematologic cancer	0.000223	0.000619	CcSEcCtD
Tirofiban—Urticaria—Alitretinoin—hematologic cancer	0.000222	0.000616	CcSEcCtD
Tirofiban—Headache—Lenalidomide—hematologic cancer	0.000222	0.000615	CcSEcCtD
Tirofiban—Haemoglobin—Prednisone—hematologic cancer	0.000221	0.000614	CcSEcCtD
Tirofiban—Body temperature increased—Alitretinoin—hematologic cancer	0.000221	0.000613	CcSEcCtD
Tirofiban—Haemorrhage—Prednisone—hematologic cancer	0.00022	0.000611	CcSEcCtD
Tirofiban—Urticaria—Ifosfamide—hematologic cancer	0.000219	0.000609	CcSEcCtD
Tirofiban—Headache—Hydroxyurea—hematologic cancer	0.000218	0.000607	CcSEcCtD
Tirofiban—Pain—Gemcitabine—hematologic cancer	0.000218	0.000606	CcSEcCtD
Tirofiban—Body temperature increased—Ifosfamide—hematologic cancer	0.000218	0.000606	CcSEcCtD
Tirofiban—Anaphylactic shock—Etoposide—hematologic cancer	0.000218	0.000605	CcSEcCtD
Tirofiban—Hypersensitivity—Thalidomide—hematologic cancer	0.000216	0.0006	CcSEcCtD
Tirofiban—Nausea—Melphalan—hematologic cancer	0.000216	0.0006	CcSEcCtD
Tirofiban—Dizziness—Bortezomib—hematologic cancer	0.000215	0.000598	CcSEcCtD
Tirofiban—Oedema—Prednisolone—hematologic cancer	0.000215	0.000597	CcSEcCtD
Tirofiban—Anaphylactic shock—Prednisolone—hematologic cancer	0.000215	0.000597	CcSEcCtD
Tirofiban—Thrombocytopenia—Etoposide—hematologic cancer	0.000213	0.000593	CcSEcCtD
Tirofiban—Body temperature increased—Vincristine—hematologic cancer	0.000213	0.000591	CcSEcCtD
Tirofiban—Hyperhidrosis—Etoposide—hematologic cancer	0.000211	0.000585	CcSEcCtD
Tirofiban—Dizziness—Vinorelbine—hematologic cancer	0.00021	0.000583	CcSEcCtD
Tirofiban—Nausea—Lenalidomide—hematologic cancer	0.00021	0.000583	CcSEcCtD
Tirofiban—Hypertension—Triamcinolone—hematologic cancer	0.000209	0.000581	CcSEcCtD
Tirofiban—Urticaria—Mitoxantrone—hematologic cancer	0.000208	0.000578	CcSEcCtD
Tirofiban—Hyperhidrosis—Prednisolone—hematologic cancer	0.000208	0.000577	CcSEcCtD
Tirofiban—Hypersensitivity—Carmustine—hematologic cancer	0.000208	0.000577	CcSEcCtD
Tirofiban—Body temperature increased—Mitoxantrone—hematologic cancer	0.000207	0.000575	CcSEcCtD
Tirofiban—Body temperature increased—Irinotecan—hematologic cancer	0.000207	0.000575	CcSEcCtD
Tirofiban—Nausea—Hydroxyurea—hematologic cancer	0.000207	0.000575	CcSEcCtD
Tirofiban—Hypersensitivity—Alitretinoin—hematologic cancer	0.000206	0.000571	CcSEcCtD
Tirofiban—Headache—Bortezomib—hematologic cancer	0.000204	0.000566	CcSEcCtD
Tirofiban—Pain—Cisplatin—hematologic cancer	0.000203	0.000565	CcSEcCtD
Tirofiban—Hypersensitivity—Ifosfamide—hematologic cancer	0.000203	0.000565	CcSEcCtD
Tirofiban—Body temperature increased—Gemcitabine—hematologic cancer	0.000202	0.00056	CcSEcCtD
Tirofiban—Dizziness—Thiotepa—hematologic cancer	0.000201	0.000557	CcSEcCtD
Tirofiban—Headache—Vinorelbine—hematologic cancer	0.000199	0.000553	CcSEcCtD
Tirofiban—Hypersensitivity—Vincristine—hematologic cancer	0.000198	0.000551	CcSEcCtD
Tirofiban—Oedema—Triamcinolone—hematologic cancer	0.000198	0.000549	CcSEcCtD
Tirofiban—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000198	0.000549	CcSEcCtD
Tirofiban—Sweating—Methotrexate—hematologic cancer	0.000196	0.000545	CcSEcCtD
Tirofiban—Haematuria—Methotrexate—hematologic cancer	0.000195	0.000542	CcSEcCtD
Tirofiban—Dizziness—Thalidomide—hematologic cancer	0.000194	0.000539	CcSEcCtD
Tirofiban—Nausea—Bortezomib—hematologic cancer	0.000193	0.000537	CcSEcCtD
Tirofiban—Hypersensitivity—Irinotecan—hematologic cancer	0.000193	0.000536	CcSEcCtD
Tirofiban—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000193	0.000536	CcSEcCtD
Tirofiban—Nausea—Bleomycin—hematologic cancer	0.000192	0.000533	CcSEcCtD
Tirofiban—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000191	0.000531	CcSEcCtD
Tirofiban—Headache—Thiotepa—hematologic cancer	0.00019	0.000528	CcSEcCtD
Tirofiban—Hypertension—Betamethasone—hematologic cancer	0.00019	0.000527	CcSEcCtD
Tirofiban—Hypertension—Dexamethasone—hematologic cancer	0.00019	0.000527	CcSEcCtD
Tirofiban—Nausea—Vinorelbine—hematologic cancer	0.000189	0.000524	CcSEcCtD
Tirofiban—Body temperature increased—Cisplatin—hematologic cancer	0.000188	0.000522	CcSEcCtD
Tirofiban—Dizziness—Carmustine—hematologic cancer	0.000186	0.000518	CcSEcCtD
Tirofiban—Pain—Etoposide—hematologic cancer	0.000186	0.000518	CcSEcCtD
Tirofiban—Haemoglobin—Methotrexate—hematologic cancer	0.000185	0.000513	CcSEcCtD
Tirofiban—Dizziness—Alitretinoin—hematologic cancer	0.000185	0.000513	CcSEcCtD
Tirofiban—Headache—Thalidomide—hematologic cancer	0.000184	0.000511	CcSEcCtD
Tirofiban—Pain—Prednisolone—hematologic cancer	0.000184	0.000511	CcSEcCtD
Tirofiban—Haemorrhage—Methotrexate—hematologic cancer	0.000184	0.00051	CcSEcCtD
Tirofiban—Sweating—Epirubicin—hematologic cancer	0.000184	0.00051	CcSEcCtD
Tirofiban—Haematuria—Epirubicin—hematologic cancer	0.000183	0.000507	CcSEcCtD
Tirofiban—Dizziness—Ifosfamide—hematologic cancer	0.000182	0.000507	CcSEcCtD
Tirofiban—Nausea—Thiotepa—hematologic cancer	0.00018	0.000501	CcSEcCtD
Tirofiban—Anaphylactic shock—Betamethasone—hematologic cancer	0.000179	0.000498	CcSEcCtD
Tirofiban—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000179	0.000498	CcSEcCtD
Tirofiban—Oedema—Dexamethasone—hematologic cancer	0.000179	0.000498	CcSEcCtD
Tirofiban—Oedema—Betamethasone—hematologic cancer	0.000179	0.000498	CcSEcCtD
Tirofiban—Dizziness—Vincristine—hematologic cancer	0.000178	0.000494	CcSEcCtD
Tirofiban—Headache—Carmustine—hematologic cancer	0.000177	0.00049	CcSEcCtD
Tirofiban—Thrombocytopenia—Betamethasone—hematologic cancer	0.000176	0.000488	CcSEcCtD
Tirofiban—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000176	0.000488	CcSEcCtD
Tirofiban—Hypersensitivity—Cisplatin—hematologic cancer	0.000175	0.000487	CcSEcCtD
Tirofiban—Bradycardia—Epirubicin—hematologic cancer	0.000175	0.000486	CcSEcCtD
Tirofiban—Headache—Alitretinoin—hematologic cancer	0.000175	0.000486	CcSEcCtD
Tirofiban—Nausea—Thalidomide—hematologic cancer	0.000174	0.000484	CcSEcCtD
Tirofiban—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000173	0.000482	CcSEcCtD
Tirofiban—Hyperhidrosis—Betamethasone—hematologic cancer	0.000173	0.000482	CcSEcCtD
Tirofiban—Dizziness—Irinotecan—hematologic cancer	0.000173	0.000481	CcSEcCtD
Tirofiban—Urticaria—Etoposide—hematologic cancer	0.000173	0.000481	CcSEcCtD
Tirofiban—Haemoglobin—Epirubicin—hematologic cancer	0.000173	0.00048	CcSEcCtD
Tirofiban—Body temperature increased—Etoposide—hematologic cancer	0.000172	0.000479	CcSEcCtD
Tirofiban—Haemorrhage—Epirubicin—hematologic cancer	0.000172	0.000478	CcSEcCtD
Tirofiban—Urticaria—Prednisolone—hematologic cancer	0.000171	0.000474	CcSEcCtD
Tirofiban—Sweating—Doxorubicin—hematologic cancer	0.00017	0.000472	CcSEcCtD
Tirofiban—Pain—Triamcinolone—hematologic cancer	0.000169	0.00047	CcSEcCtD
Tirofiban—Haematuria—Doxorubicin—hematologic cancer	0.000169	0.000469	CcSEcCtD
Tirofiban—Headache—Vincristine—hematologic cancer	0.000169	0.000468	CcSEcCtD
Tirofiban—Nausea—Carmustine—hematologic cancer	0.000167	0.000465	CcSEcCtD
Tirofiban—Nausea—Alitretinoin—hematologic cancer	0.000166	0.000461	CcSEcCtD
Tirofiban—Hypertension—Prednisone—hematologic cancer	0.000165	0.000459	CcSEcCtD
Tirofiban—Chills—Methotrexate—hematologic cancer	0.000165	0.000458	CcSEcCtD
Tirofiban—Headache—Mitoxantrone—hematologic cancer	0.000164	0.000456	CcSEcCtD
Tirofiban—Headache—Irinotecan—hematologic cancer	0.000164	0.000456	CcSEcCtD
Tirofiban—Nausea—Ifosfamide—hematologic cancer	0.000164	0.000455	CcSEcCtD
Tirofiban—Bradycardia—Doxorubicin—hematologic cancer	0.000162	0.00045	CcSEcCtD
Tirofiban—Hypersensitivity—Etoposide—hematologic cancer	0.000161	0.000446	CcSEcCtD
Tirofiban—Haemoglobin—Doxorubicin—hematologic cancer	0.00016	0.000444	CcSEcCtD
Tirofiban—Headache—Gemcitabine—hematologic cancer	0.00016	0.000444	CcSEcCtD
Tirofiban—Nausea—Vincristine—hematologic cancer	0.00016	0.000444	CcSEcCtD
Tirofiban—Haemorrhage—Doxorubicin—hematologic cancer	0.000159	0.000442	CcSEcCtD
Tirofiban—Hypersensitivity—Prednisolone—hematologic cancer	0.000158	0.00044	CcSEcCtD
Tirofiban—Urticaria—Triamcinolone—hematologic cancer	0.000157	0.000436	CcSEcCtD
Tirofiban—Body temperature increased—Triamcinolone—hematologic cancer	0.000156	0.000434	CcSEcCtD
Tirofiban—Anaphylactic shock—Prednisone—hematologic cancer	0.000156	0.000434	CcSEcCtD
Tirofiban—Oedema—Prednisone—hematologic cancer	0.000156	0.000434	CcSEcCtD
Tirofiban—Nausea—Mitoxantrone—hematologic cancer	0.000156	0.000432	CcSEcCtD
Tirofiban—Nausea—Irinotecan—hematologic cancer	0.000156	0.000432	CcSEcCtD
Tirofiban—Chills—Epirubicin—hematologic cancer	0.000154	0.000429	CcSEcCtD
Tirofiban—Pain—Dexamethasone—hematologic cancer	0.000153	0.000426	CcSEcCtD
Tirofiban—Pain—Betamethasone—hematologic cancer	0.000153	0.000426	CcSEcCtD
Tirofiban—Nausea—Gemcitabine—hematologic cancer	0.000152	0.000421	CcSEcCtD
Tirofiban—Hyperhidrosis—Prednisone—hematologic cancer	0.000151	0.000419	CcSEcCtD
Tirofiban—Hypersensitivity—Triamcinolone—hematologic cancer	0.000146	0.000405	CcSEcCtD
Tirofiban—Dizziness—Etoposide—hematologic cancer	0.000144	0.0004	CcSEcCtD
Tirofiban—Chills—Doxorubicin—hematologic cancer	0.000143	0.000397	CcSEcCtD
Tirofiban—Urticaria—Dexamethasone—hematologic cancer	0.000143	0.000396	CcSEcCtD
Tirofiban—Urticaria—Betamethasone—hematologic cancer	0.000143	0.000396	CcSEcCtD
Tirofiban—Dizziness—Prednisolone—hematologic cancer	0.000142	0.000395	CcSEcCtD
Tirofiban—Body temperature increased—Dexamethasone—hematologic cancer	0.000142	0.000394	CcSEcCtD
Tirofiban—Body temperature increased—Betamethasone—hematologic cancer	0.000142	0.000394	CcSEcCtD
Tirofiban—Nausea—Cisplatin—hematologic cancer	0.000141	0.000392	CcSEcCtD
Tirofiban—Headache—Etoposide—hematologic cancer	0.000137	0.000379	CcSEcCtD
Tirofiban—Headache—Prednisolone—hematologic cancer	0.000135	0.000374	CcSEcCtD
Tirofiban—Dizziness—Triamcinolone—hematologic cancer	0.000131	0.000363	CcSEcCtD
Tirofiban—Anaphylactic shock—Methotrexate—hematologic cancer	0.000131	0.000363	CcSEcCtD
Tirofiban—Nausea—Etoposide—hematologic cancer	0.000129	0.00036	CcSEcCtD
Tirofiban—Hypertension—Epirubicin—hematologic cancer	0.000129	0.000359	CcSEcCtD
Tirofiban—Thrombocytopenia—Methotrexate—hematologic cancer	0.000128	0.000355	CcSEcCtD
Tirofiban—Nausea—Prednisolone—hematologic cancer	0.000128	0.000355	CcSEcCtD
Tirofiban—Hyperhidrosis—Methotrexate—hematologic cancer	0.000126	0.000351	CcSEcCtD
Tirofiban—Urticaria—Prednisone—hematologic cancer	0.000124	0.000345	CcSEcCtD
Tirofiban—Headache—Triamcinolone—hematologic cancer	0.000124	0.000344	CcSEcCtD
Tirofiban—Body temperature increased—Prednisone—hematologic cancer	0.000123	0.000343	CcSEcCtD
Tirofiban—Anaphylactic shock—Epirubicin—hematologic cancer	0.000122	0.000339	CcSEcCtD
Tirofiban—Oedema—Epirubicin—hematologic cancer	0.000122	0.000339	CcSEcCtD
Tirofiban—Thrombocytopenia—Epirubicin—hematologic cancer	0.00012	0.000332	CcSEcCtD
Tirofiban—Hypertension—Doxorubicin—hematologic cancer	0.00012	0.000332	CcSEcCtD
Tirofiban—Dizziness—Dexamethasone—hematologic cancer	0.000119	0.000329	CcSEcCtD
Tirofiban—Dizziness—Betamethasone—hematologic cancer	0.000119	0.000329	CcSEcCtD
Tirofiban—Hyperhidrosis—Epirubicin—hematologic cancer	0.000118	0.000328	CcSEcCtD
Tirofiban—Nausea—Triamcinolone—hematologic cancer	0.000117	0.000326	CcSEcCtD
Tirofiban—Hypersensitivity—Prednisone—hematologic cancer	0.000115	0.00032	CcSEcCtD
Tirofiban—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000113	0.000314	CcSEcCtD
Tirofiban—Oedema—Doxorubicin—hematologic cancer	0.000113	0.000314	CcSEcCtD
Tirofiban—Headache—Dexamethasone—hematologic cancer	0.000112	0.000312	CcSEcCtD
Tirofiban—Headache—Betamethasone—hematologic cancer	0.000112	0.000312	CcSEcCtD
Tirofiban—Pain—Methotrexate—hematologic cancer	0.000112	0.00031	CcSEcCtD
Tirofiban—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000111	0.000307	CcSEcCtD
Tirofiban—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000109	0.000304	CcSEcCtD
Tirofiban—Nausea—Dexamethasone—hematologic cancer	0.000107	0.000296	CcSEcCtD
Tirofiban—Nausea—Betamethasone—hematologic cancer	0.000107	0.000296	CcSEcCtD
Tirofiban—Pain—Epirubicin—hematologic cancer	0.000104	0.00029	CcSEcCtD
Tirofiban—Urticaria—Methotrexate—hematologic cancer	0.000104	0.000288	CcSEcCtD
Tirofiban—Dizziness—Prednisone—hematologic cancer	0.000103	0.000287	CcSEcCtD
Tirofiban—Body temperature increased—Methotrexate—hematologic cancer	0.000103	0.000287	CcSEcCtD
Tirofiban—Headache—Prednisone—hematologic cancer	9.79e-05	0.000272	CcSEcCtD
Tirofiban—Urticaria—Epirubicin—hematologic cancer	9.71e-05	0.00027	CcSEcCtD
Tirofiban—Pain—Doxorubicin—hematologic cancer	9.67e-05	0.000268	CcSEcCtD
Tirofiban—Body temperature increased—Epirubicin—hematologic cancer	9.66e-05	0.000268	CcSEcCtD
Tirofiban—Hypersensitivity—Methotrexate—hematologic cancer	9.62e-05	0.000267	CcSEcCtD
Tirofiban—Nausea—Prednisone—hematologic cancer	9.28e-05	0.000258	CcSEcCtD
Tirofiban—Hypersensitivity—Epirubicin—hematologic cancer	9e-05	0.00025	CcSEcCtD
Tirofiban—Urticaria—Doxorubicin—hematologic cancer	8.98e-05	0.000249	CcSEcCtD
Tirofiban—Body temperature increased—Doxorubicin—hematologic cancer	8.94e-05	0.000248	CcSEcCtD
Tirofiban—Dizziness—Methotrexate—hematologic cancer	8.63e-05	0.00024	CcSEcCtD
Tirofiban—Hypersensitivity—Doxorubicin—hematologic cancer	8.33e-05	0.000231	CcSEcCtD
Tirofiban—Headache—Methotrexate—hematologic cancer	8.18e-05	0.000227	CcSEcCtD
Tirofiban—Dizziness—Epirubicin—hematologic cancer	8.08e-05	0.000224	CcSEcCtD
Tirofiban—Nausea—Methotrexate—hematologic cancer	7.75e-05	0.000215	CcSEcCtD
Tirofiban—Headache—Epirubicin—hematologic cancer	7.65e-05	0.000213	CcSEcCtD
Tirofiban—Dizziness—Doxorubicin—hematologic cancer	7.48e-05	0.000208	CcSEcCtD
Tirofiban—Nausea—Epirubicin—hematologic cancer	7.26e-05	0.000202	CcSEcCtD
Tirofiban—Headache—Doxorubicin—hematologic cancer	7.08e-05	0.000197	CcSEcCtD
Tirofiban—Nausea—Doxorubicin—hematologic cancer	6.71e-05	0.000186	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—SDC1—hematologic cancer	4.96e-05	0.000104	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	4.94e-05	0.000104	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AGO2—hematologic cancer	4.93e-05	0.000104	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SPHK1—hematologic cancer	4.93e-05	0.000104	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MAP2K1—hematologic cancer	4.92e-05	0.000103	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HDAC9—hematologic cancer	4.88e-05	0.000102	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LPAR1—hematologic cancer	4.88e-05	0.000102	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—H3F3B—hematologic cancer	4.83e-05	0.000101	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTGER4—hematologic cancer	4.83e-05	0.000101	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—LCK—hematologic cancer	4.8e-05	0.000101	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CD—hematologic cancer	4.79e-05	0.000101	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—SRC—hematologic cancer	4.78e-05	0.0001	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—ALB—hematologic cancer	4.73e-05	9.93e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—H3F3A—hematologic cancer	4.71e-05	9.88e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—FGF2—hematologic cancer	4.68e-05	9.82e-05	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—VEGFA—hematologic cancer	4.66e-05	9.77e-05	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—NRAS—hematologic cancer	4.6e-05	9.66e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PRKCZ—hematologic cancer	4.58e-05	9.6e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—EP300—hematologic cancer	4.56e-05	9.56e-05	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—AKT1—hematologic cancer	4.56e-05	9.56e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3R1—hematologic cancer	4.53e-05	9.5e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PDE4B—hematologic cancer	4.49e-05	9.43e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CNR2—hematologic cancer	4.49e-05	9.43e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—JAK2—hematologic cancer	4.48e-05	9.41e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—EP300—hematologic cancer	4.47e-05	9.38e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGF19—hematologic cancer	4.46e-05	9.35e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—SRC—hematologic cancer	4.43e-05	9.3e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RAC2—hematologic cancer	4.42e-05	9.27e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PARP1—hematologic cancer	4.42e-05	9.27e-05	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MAPK3—hematologic cancer	4.41e-05	9.25e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—JAK2—hematologic cancer	4.4e-05	9.23e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—DKK1—hematologic cancer	4.39e-05	9.2e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—HRAS—hematologic cancer	4.37e-05	9.17e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—STAT5B—hematologic cancer	4.35e-05	9.13e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FBXW7—hematologic cancer	4.35e-05	9.12e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—SRC—hematologic cancer	4.35e-05	9.12e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—VEGFA—hematologic cancer	4.32e-05	9.05e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—STAT3—hematologic cancer	4.27e-05	8.97e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HDAC2—hematologic cancer	4.26e-05	8.95e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCR4—hematologic cancer	4.26e-05	8.95e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—NRAS—hematologic cancer	4.26e-05	8.94e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—VEGFA—hematologic cancer	4.23e-05	8.88e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ADCY7—hematologic cancer	4.22e-05	8.86e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—IL6—hematologic cancer	4.18e-05	8.78e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—NRAS—hematologic cancer	4.18e-05	8.77e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CB—hematologic cancer	4.18e-05	8.77e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CBL—hematologic cancer	4.16e-05	8.72e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL3—hematologic cancer	4.11e-05	8.63e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—XIAP—hematologic cancer	4.11e-05	8.62e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MAPK3—hematologic cancer	4.08e-05	8.57e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTPN1—hematologic cancer	4.04e-05	8.48e-05	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	4.04e-05	8.47e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—MAPK3—hematologic cancer	4e-05	8.4e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SH2B3—hematologic cancer	4e-05	8.4e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SMARCA4—hematologic cancer	4e-05	8.4e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GZMB—hematologic cancer	3.98e-05	8.35e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RASGRP1—hematologic cancer	3.98e-05	8.35e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SYK—hematologic cancer	3.96e-05	8.32e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HSP90AA1—hematologic cancer	3.96e-05	8.32e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TGFB1—hematologic cancer	3.96e-05	8.31e-05	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—KRAS—hematologic cancer	3.96e-05	8.31e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CTNNA1—hematologic cancer	3.89e-05	8.15e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TGFB1—hematologic cancer	3.89e-05	8.15e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EIF4EBP1—hematologic cancer	3.86e-05	8.11e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HSPB1—hematologic cancer	3.86e-05	8.11e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCL3—hematologic cancer	3.86e-05	8.11e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IL2—hematologic cancer	3.84e-05	8.05e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—STAT1—hematologic cancer	3.82e-05	8.02e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SDC1—hematologic cancer	3.82e-05	8.02e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTHLH—hematologic cancer	3.82e-05	8.02e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTGER4—hematologic cancer	3.72e-05	7.8e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LCK—hematologic cancer	3.7e-05	7.76e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TNF—hematologic cancer	3.7e-05	7.76e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—KRAS—hematologic cancer	3.67e-05	7.7e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—H3F3A—hematologic cancer	3.63e-05	7.61e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—KRAS—hematologic cancer	3.6e-05	7.55e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—GRB2—hematologic cancer	3.58e-05	7.5e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PDGFA—hematologic cancer	3.57e-05	7.49e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PRKCZ—hematologic cancer	3.53e-05	7.4e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KITLG—hematologic cancer	3.52e-05	7.38e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—EP300—hematologic cancer	3.51e-05	7.36e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—EP300—hematologic cancer	3.44e-05	7.22e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—STAT5A—hematologic cancer	3.44e-05	7.21e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—SRC—hematologic cancer	3.41e-05	7.16e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN2B—hematologic cancer	3.41e-05	7.15e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PARP1—hematologic cancer	3.41e-05	7.14e-05	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—HRAS—hematologic cancer	3.37e-05	7.06e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FBXW7—hematologic cancer	3.35e-05	7.03e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—SRC—hematologic cancer	3.35e-05	7.03e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—VEGFA—hematologic cancer	3.32e-05	6.98e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PIK3CA—hematologic cancer	3.31e-05	6.94e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CD86—hematologic cancer	3.3e-05	6.91e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—STAT3—hematologic cancer	3.29e-05	6.91e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HDAC2—hematologic cancer	3.29e-05	6.89e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCR4—hematologic cancer	3.29e-05	6.89e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—NRAS—hematologic cancer	3.28e-05	6.89e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—VEGFA—hematologic cancer	3.26e-05	6.84e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HES1—hematologic cancer	3.25e-05	6.82e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NCOR1—hematologic cancer	3.23e-05	6.78e-05	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—IL6—hematologic cancer	3.22e-05	6.76e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—NRAS—hematologic cancer	3.22e-05	6.76e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CBL—hematologic cancer	3.2e-05	6.72e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TP53—hematologic cancer	3.2e-05	6.71e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGF1—hematologic cancer	3.2e-05	6.71e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CSF2—hematologic cancer	3.2e-05	6.71e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL3—hematologic cancer	3.17e-05	6.65e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FOXO1—hematologic cancer	3.15e-05	6.61e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MAPK3—hematologic cancer	3.14e-05	6.6e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PDGFRB—hematologic cancer	3.14e-05	6.6e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—HRAS—hematologic cancer	3.12e-05	6.54e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTPN1—hematologic cancer	3.11e-05	6.53e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PDGFRA—hematologic cancer	3.1e-05	6.49e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—MAPK3—hematologic cancer	3.08e-05	6.47e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PRKCG—hematologic cancer	3.08e-05	6.47e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—JAK1—hematologic cancer	3.08e-05	6.47e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RASGRP1—hematologic cancer	3.06e-05	6.43e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—HRAS—hematologic cancer	3.06e-05	6.42e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SYK—hematologic cancer	3.05e-05	6.41e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HSP90AA1—hematologic cancer	3.05e-05	6.41e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TGFB1—hematologic cancer	3.05e-05	6.4e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TGFB1—hematologic cancer	2.99e-05	6.28e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—IL6—hematologic cancer	2.98e-05	6.26e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—STAT1—hematologic cancer	2.94e-05	6.18e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL2RA—hematologic cancer	2.88e-05	6.04e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TNF—hematologic cancer	2.85e-05	5.98e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TERT—hematologic cancer	2.85e-05	5.98e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—KRAS—hematologic cancer	2.83e-05	5.93e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PDGFB—hematologic cancer	2.78e-05	5.83e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—KRAS—hematologic cancer	2.77e-05	5.82e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GRB2—hematologic cancer	2.76e-05	5.78e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—AKT1—hematologic cancer	2.75e-05	5.78e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PDGFA—hematologic cancer	2.75e-05	5.77e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TSC2—hematologic cancer	2.72e-05	5.7e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KITLG—hematologic cancer	2.71e-05	5.68e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—AKT1—hematologic cancer	2.7e-05	5.67e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—STAT5A—hematologic cancer	2.65e-05	5.56e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN2B—hematologic cancer	2.62e-05	5.51e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGFR3—hematologic cancer	2.61e-05	5.48e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAPK14—hematologic cancer	2.59e-05	5.43e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CA—hematologic cancer	2.55e-05	5.34e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ESR1—hematologic cancer	2.54e-05	5.33e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CD86—hematologic cancer	2.54e-05	5.33e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FN1—hematologic cancer	2.51e-05	5.26e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HES1—hematologic cancer	2.5e-05	5.25e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NCOR1—hematologic cancer	2.49e-05	5.22e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—BAD—hematologic cancer	2.48e-05	5.2e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NFKBIA—hematologic cancer	2.48e-05	5.2e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TP53—hematologic cancer	2.46e-05	5.17e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGF1—hematologic cancer	2.46e-05	5.17e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CSF2—hematologic cancer	2.46e-05	5.17e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NOTCH1—hematologic cancer	2.45e-05	5.15e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FOXO1—hematologic cancer	2.43e-05	5.09e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PDGFRB—hematologic cancer	2.42e-05	5.08e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CD80—hematologic cancer	2.4e-05	5.04e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—HRAS—hematologic cancer	2.4e-05	5.04e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KIT—hematologic cancer	2.4e-05	5.04e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CG—hematologic cancer	2.4e-05	5.04e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PDGFRA—hematologic cancer	2.38e-05	5e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PRKCG—hematologic cancer	2.38e-05	4.99e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—JAK1—hematologic cancer	2.38e-05	4.99e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTPN11—hematologic cancer	2.36e-05	4.95e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—HRAS—hematologic cancer	2.36e-05	4.94e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—IL6—hematologic cancer	2.3e-05	4.82e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CREB1—hematologic cancer	2.28e-05	4.79e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—BRAF—hematologic cancer	2.26e-05	4.73e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCL2—hematologic cancer	2.24e-05	4.69e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6R—hematologic cancer	2.23e-05	4.68e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CREBBP—hematologic cancer	2.23e-05	4.67e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL2RA—hematologic cancer	2.22e-05	4.66e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TERT—hematologic cancer	2.19e-05	4.6e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PDGFB—hematologic cancer	2.14e-05	4.49e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAP2K1—hematologic cancer	2.12e-05	4.46e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—AKT1—hematologic cancer	2.12e-05	4.45e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CD—hematologic cancer	2.11e-05	4.43e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TSC2—hematologic cancer	2.09e-05	4.39e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—AKT1—hematologic cancer	2.08e-05	4.37e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGF2—hematologic cancer	2.02e-05	4.24e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGFR3—hematologic cancer	2.01e-05	4.22e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAPK14—hematologic cancer	1.99e-05	4.18e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3R1—hematologic cancer	1.99e-05	4.18e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ESR1—hematologic cancer	1.96e-05	4.1e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—JAK2—hematologic cancer	1.94e-05	4.06e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FN1—hematologic cancer	1.93e-05	4.05e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NFKBIA—hematologic cancer	1.91e-05	4.01e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—BAD—hematologic cancer	1.91e-05	4.01e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NOTCH1—hematologic cancer	1.89e-05	3.97e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MDM2—hematologic cancer	1.89e-05	3.97e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CD80—hematologic cancer	1.85e-05	3.89e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CG—hematologic cancer	1.85e-05	3.88e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KIT—hematologic cancer	1.85e-05	3.88e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CB—hematologic cancer	1.84e-05	3.86e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MTOR—hematologic cancer	1.84e-05	3.86e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTPN11—hematologic cancer	1.82e-05	3.81e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CREB1—hematologic cancer	1.76e-05	3.69e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—BRAF—hematologic cancer	1.74e-05	3.65e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN1B—hematologic cancer	1.73e-05	3.62e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCL2—hematologic cancer	1.72e-05	3.61e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6R—hematologic cancer	1.72e-05	3.6e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CREBBP—hematologic cancer	1.71e-05	3.6e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CASP3—hematologic cancer	1.69e-05	3.55e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL2—hematologic cancer	1.69e-05	3.54e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCND1—hematologic cancer	1.65e-05	3.45e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—JUN—hematologic cancer	1.64e-05	3.45e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAP2K1—hematologic cancer	1.64e-05	3.43e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CD—hematologic cancer	1.63e-05	3.41e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN1A—hematologic cancer	1.59e-05	3.34e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTEN—hematologic cancer	1.59e-05	3.33e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGF2—hematologic cancer	1.56e-05	3.26e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAPK8—hematologic cancer	1.55e-05	3.26e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3R1—hematologic cancer	1.53e-05	3.22e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EP300—hematologic cancer	1.52e-05	3.18e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—JAK2—hematologic cancer	1.49e-05	3.13e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SRC—hematologic cancer	1.47e-05	3.09e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MDM2—hematologic cancer	1.46e-05	3.05e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—VEGFA—hematologic cancer	1.44e-05	3.01e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—STAT3—hematologic cancer	1.42e-05	2.98e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NRAS—hematologic cancer	1.42e-05	2.97e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MTOR—hematologic cancer	1.42e-05	2.97e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CB—hematologic cancer	1.42e-05	2.97e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAPK3—hematologic cancer	1.36e-05	2.85e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN1B—hematologic cancer	1.33e-05	2.79e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MYC—hematologic cancer	1.32e-05	2.77e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TGFB1—hematologic cancer	1.32e-05	2.76e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CASP3—hematologic cancer	1.3e-05	2.73e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL2—hematologic cancer	1.3e-05	2.73e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCND1—hematologic cancer	1.27e-05	2.66e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—JUN—hematologic cancer	1.27e-05	2.66e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN1A—hematologic cancer	1.23e-05	2.57e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTEN—hematologic cancer	1.22e-05	2.57e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KRAS—hematologic cancer	1.22e-05	2.56e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAPK8—hematologic cancer	1.2e-05	2.51e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EP300—hematologic cancer	1.17e-05	2.45e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SRC—hematologic cancer	1.14e-05	2.38e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CA—hematologic cancer	1.12e-05	2.35e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VEGFA—hematologic cancer	1.11e-05	2.32e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—STAT3—hematologic cancer	1.09e-05	2.3e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NRAS—hematologic cancer	1.09e-05	2.29e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—hematologic cancer	1.08e-05	2.28e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAPK3—hematologic cancer	1.05e-05	2.19e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HRAS—hematologic cancer	1.04e-05	2.18e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MYC—hematologic cancer	1.02e-05	2.13e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TGFB1—hematologic cancer	1.01e-05	2.13e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6—hematologic cancer	9.93e-06	2.08e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KRAS—hematologic cancer	9.4e-06	1.97e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AKT1—hematologic cancer	9.16e-06	1.92e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CA—hematologic cancer	8.64e-06	1.81e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—hematologic cancer	8.35e-06	1.75e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HRAS—hematologic cancer	7.99e-06	1.68e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6—hematologic cancer	7.65e-06	1.6e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AKT1—hematologic cancer	7.05e-06	1.48e-05	CbGpPWpGaD
